ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BLCO Bausch and Lomb Corporation

25.60
-0.20 (-0.78%)
30 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bausch and Lomb Corporation TSX:BLCO Toronto Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -0.78% 25.60 23.75 25.80 25.97 25.45 25.80 720 22:00:00

Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference

07/11/2022 12:00pm

PR Newswire (US)


Bausch and Lomb (TSX:BLCO)
Historical Stock Chart


From Jan 2022 to Jan 2025

Click Here for more Bausch and Lomb Charts.

VAUGHAN, ON, Nov. 7, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief executive officer, and Sam Eldessouky, executive vice president and chief financial officer are scheduled to participate at the 5th Annual Evercore ISI HealthCONx Conference on Nov. 30, 2022, at 9:40 a.m. ET.

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch + Lomb website at: https://ir.bausch.com/investors/events-presentations.

About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

Investor Contact:

Media Contact:

Arthur Shannon 

Lainie Keller

arthur.shannon@bausch.com 

lainie.keller@bausch.com


(908) 927-1198

Allison Ryan 


Allison.ryan@bausch.com 

Kristy Marks 

(877) 354-3705 (toll free) 

kristy.marks@bausch.com 


(908) 927-0683

 

Bausch + Lomb (PRNewsfoto/Bausch + Lomb Corporation)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch--lomb-announces-participation-at-the-5th-annual-evercore-isi-healthconx-conference-301668445.html

SOURCE Bausch + Lomb Corporation

Copyright 2022 PR Newswire

1 Year Bausch and Lomb Chart

1 Year Bausch and Lomb Chart

1 Month Bausch and Lomb Chart

1 Month Bausch and Lomb Chart

Your Recent History

Delayed Upgrade Clock